Saturday, May 4, 2019, 5:00 pm
18
Improving the Cataract Patient Experience:
Minimizing Pain and Inflammation while
Reducing the Need for Topical Drops
San Diego Convention Center – Room 20D
5:00 – 5:30 pm Registration (and reception)
5:30 – 6:30 pm Program
Program Chairs: Eric D. Donnenfeld, MD
Edward J. Holland, MD
Faculty: Alice T. Epitropoulos, MD
Denise M. Visco, MD, MBA
William F. Wiley, MD
These activities are approved for
AMA PRA Category 1 Credits.
TM
Educational Objectives
Ophthalmologists who attend this course will:
• Compare and contrast current and emerging regimens and pharmaceutical approaches for the prevention of pain and inflammation in cataract
surgery, including alternative therapeutic options designed to overcome patient compliance concerns and reduce ocular toxicity
• Advanced topical medications
• Intracameral medications
• Sustained release technologies
• Determine adjustments needed to pre-, intra-, and postoperative steroid and NSAID regimens for patients at greater risk for inflammation
• Discuss cataract patients' perceptions of intra- and postoperative pain and the impact that it has on surgical outcomes and patient satisfaction
• Describe evolving reimbursement models to expand access to new approaches to control pain and inflammation after cataract surgery
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for
Continuing Medical Education (ACCME) through the joint providership of the American Society of Cataract and Refractive Surgery (ASCRS) and
EyeWorld news magazine. ASCRS is accredited by the ACCME to provide continuing medical education for physicians. ASCRS takes responsibility for the
content, quality, and scientific integrity of this CME activity.
